Pharma Talk

Showing posts with the label #FDAWarningLetters #PharmaQuality #cGMP #GMPInspections #RegulatoryAffairs #QualityAssurance #PharmaceuticalManufacturing #DataIntegrity #MicrobiologyControls #FDACompliance #EMAGuidance #GMPAudits #

The pharmaceutical industry continues to face rigorous scrutiny from regulatory authorities

Sayed Mahaboob Subhani February 08, 2026

The pharmaceutical industry continues to face rigorous scrutiny from regulatory authorities like th…

Pharma Talk

The pharmaceutical industry continues to face rigorous scrutiny from regulatory authorities

Latest FDA Insights: Critical Data Integrity and OOS Issues in Recent GMP Inspections (December 2025 Update)

Analytical Method Performance USP 1221

Guidance Documents on Variation Notifications Updated

FDA Warning Letter Highlights Critical Gaps in Analytical Testing and CGMP Oversight at Taiwanese OTC Manufacturer

WHO Draft Guidance on Quality Risk Management: Practical Insights for Lifecycle Application

What is PDCA Cycle

Contact Form